Mexico’s 2019 HPV Photodynamic Therapy Results: What They Showed

Facebook ↗WhatsApp ↗

Originally published 2019-03-13.

In February 2019 Mexico's National Polytechnic Institute (IPN) announced that a team led by biologist Eva Ramón Gallegos had eliminated human papillomavirus (HPV) in patients using photodynamic therapy, a treatment that combines a light-sensitive drug with a beam of light. Headlines around the world called it a cure for HPV.

The results were encouraging but narrower than that. According to El Universal, the virus disappeared in every treated woman who had HPV without precancerous changes, in 64.3 percent of women who had HPV together with lesions, and in 57.2 percent of women who had lesions without detectable HPV. Photodynamic therapy is a promising option for some HPV infections and early cervical lesions. It is not a cure for every HPV infection, and it does not replace vaccination or screening.

Mexico's 2019 Photodynamic-Therapy Research on HPV

What the IPN team announced

Ramón Gallegos, a researcher at the IPN's National School of Biological Sciences, presented the work around World Cancer Day 2019 as the outcome of roughly 20 years of research. Her group, made up largely of women scientists, had been studying photodynamic therapy as a way to stop or reverse precancerous changes and some early tumours.


The treatment had been given to about 420 patients in the states of Oaxaca and Veracruz, an earlier stage that she described as encouraging, and later to 29 women in Mexico City. It was those 29 women who were widely reported as cured, although the public announcement did not break down how many patients fell into each result group.

How photodynamic therapy works

Photodynamic therapy has two parts. First a photosensitising drug is applied; in Ramón Gallegos's published work this was a gel of 5-aminolevulinic acid (5-ALA) placed on the cervix for several hours. Abnormal and infected cells take up more of the drug than healthy ones. The area is then lit with red light at a specific wavelength, which triggers a reaction that produces toxic forms of oxygen inside the marked cells and destroys them.

The appeal is precision. In an interview with Cuba's Radio Guamá she said the method "only eliminates damaged cells and does not affect healthy structures", which could spare the cervix from the cutting or freezing used in standard treatments. Before treatment, patients were assessed with colposcopy, a Pap smear, HPV DNA tests (hybrid capture and PCR) and a biopsy, so the team knew who had the virus, who had lesions, and who had both.

Photodynamic therapy is not new in itself. It is already approved in many countries for some skin precancers and skin cancers, and doctors have tested it on the cervix for years. What made the Mexican work notable was its focus on clearing the virus as well as the lesions.

What the numbers do and do not show

The clearest published account of the method is a 2017 paper in Photochemistry and Photobiology, which followed 30 Mexican women with HPV infection, low-grade cervical lesions (CIN 1) or both. They received three sessions 48 hours apart. HPV cleared in 80 percent of women with infection alone and in 83 percent of those whose infection came with CIN 1, while the lesions themselves regressed in 57 percent at 12 months, a figure that was not statistically significant.

Those are respectable results, but the study had no comparison group. That matters because most HPV infections clear on their own: the World Health Organization notes that the immune system removes the virus in most cases, usually within a couple of years and without symptoms. Without a group that received no treatment or a standard treatment, it is impossible to say how much of the clearance was caused by the light therapy.

The discovery, made by a team led by Mexican woman Eva Ramon Gallegos, could save countless lives. pic.twitter.com/U5RSl3TpiI

— teleSUR English (@telesurenglish) February 8, 2019

(This post is no longer available on X.)


Early news stories also claimed the therapy had no side effects at all. Photodynamic treatment is generally well tolerated, but it can cause local pain, burning, discharge or temporary sensitivity, and serious side effects can only be ruled out in larger, longer trials. A small study is a starting point for that work, not the end of it.

HPV and cervical cancer: the bigger picture

HPV is the most common sexually transmitted infection. It spreads through skin-to-skin genital contact, there are well over a hundred types, and only a minority of persistent infections with high-risk types go on to cause cancer, usually after 15 to 20 years. The World Health Organization attributes about 76 percent of cervical cancers to just two types, HPV 16 and HPV 18. HPV also causes genital warts and some cancers of the anus, penis, mouth and throat.

Cervical cancer remains one of the most common cancers in women worldwide, with roughly 600,000 new cases and hundreds of thousands of deaths a year, most of them in low- and middle-income countries.


Some 2019 reports said cervical cancer killed 32,439 Mexican women in 2018, or 89 a day. That figure is far too high for this one disease. Estimates from the ICO/IARC HPV Information Centre put the toll at about 9,400 new cases and 4,300 deaths in Mexico in 2020, still a heavy burden and the second most common cancer among Mexican women.

Stigma, sex education and one patient's story

Ramón Gallegos framed her work partly as a response to how HPV is treated socially. Mexican reporting at the time, including the outlet Sin Embargo, described rising HPV infections and unplanned pregnancies among teenagers and young women, linked to patchy sex education and to conservative and religious groups opposing new sex-education material in schools.

One of the Mexico City patients, 52-year-old Lorena Guzmán, told reporters she had felt judged for carrying the virus, as if it could only come from promiscuity. In reality HPV is so widespread that most sexually active people meet it at some point. After a year of follow-up she tested negative and spoke of finally being able to plan for the future.

Ramón Gallegos also warned that bureaucracy and cuts to science budgets were slowing work like hers, a common complaint among Mexican researchers in 2019.

What prevents cervical cancer today

The tools that already save the most lives are well established:

  • Vaccination. HPV vaccines are most effective when given to girls aged 9 to 14, before they become sexually active, and many countries also vaccinate boys. One or two doses are enough for most young people.
  • Screening. WHO recommends an HPV test every five to ten years from age 30, or every three to five years from 25 for women living with HIV. Self-collected samples work as well as samples taken by a clinician.
  • Treating precancer. Abnormal areas found at screening can be removed with thermal ablation, cryotherapy or a small excision (LEEP) before cancer develops, often in the same visit.

Photodynamic therapy could one day join that list as a gentler option, particularly for younger women who want to avoid procedures that can affect later pregnancies. That depends on larger controlled trials. Anyone with an abnormal Pap or HPV result should talk to a doctor about the treatments available to them now.

Sources: El Universal, Mexican scientist cures human papilloma virus (2019); Maldonado Alvarado, Ramón Gallegos et al., Photochemistry and Photobiology 2017; WHO fact sheet on HPV and cervical cancer; ICO/IARC HPV Information Centre, Mexico report; IPN, teleSUR and WHO posts on X; patient and researcher interviews as reported by Radio Guamá, Sin Embargo and The Mind Unleashed.

COMMENTS